Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Apr 20:9:865489.
doi: 10.3389/fnut.2022.865489. eCollection 2022.

Low Carbohydrate Diets for Diabetic Cardiomyopathy: A Hypothesis

Affiliations

Low Carbohydrate Diets for Diabetic Cardiomyopathy: A Hypothesis

Sabine Kleissl-Muir et al. Front Nutr. .

Abstract

Elevated blood glucose levels, insulin resistance (IR), hyperinsulinemia and dyslipidemia the key aspects of type 2 diabetes mellitus (T2DM), contribute to the development of a certain form of cardiomyopathy. This cardiomyopathy, also known as diabetic cardiomyopathy (DMCM), typically occurs in the absence of overt coronary artery disease (CAD), hypertension or valvular disease. DMCM encompasses a variety of pathophysiological processes impacting the myocardium, hence increasing the risk for heart failure (HF) and significantly worsening outcomes in this population. Low fat (LF), calorie-restricted diets have been suggested as the preferred eating pattern for patients with HF. However, LF diets are naturally higher in carbohydrates (CHO). We argue that in an insulin resistant state, such as in DMCM, LF diets may worsen glycaemic control and promote further insulin resistance (IR), contributing to a physiological and functional decline in DMCM. We postulate that CHO restriction targeting hyperinsulinemia may be able to improve tissue and systemic IR. In recent years low carbohydrate diets (LC) including ketogenic diets (KD), have emerged as a safe and effective tool for the management of various clinical conditions such as T2DM and other metabolic disorders. CHO restriction achieves sustained glycaemic control, lower insulin levels and successfully reverses IR. In addition to this, its pleiotropic effects may present a metabolic stress defense and facilitate improvement to cardiac function in patients with HF. We therefore hypothesize that patients who adopt a LC diet may require less medications and experience improvements in HF-related symptom burden.

Keywords: diabetes; diabetic cardiomyopathy; heart failure; insulin resistance; ketogenic diet; low carbohydrate diet.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Comparison of benefits and risks of SGLT2i and LC diets. *Risks associated with the LC Diet are typically mild in severity and transient in nature. Number of arrows reflects magnitude of the intervention's effect.

Similar articles

Cited by

References

    1. International Diabetes Federation . Diabetes Globally. Diabetes Atlas Key Findings. Brussels: International Diabetes Federation; (2019). Available online at: https://www.diabetesatlas.org/en/sections/worldwide-toll-of-diabetes.html (accessed November 11, 2020).
    1. Atherton JJ, Sindone A, De Pasquale CG, Driscoll A, MacDonald PS, Hopper I, et al. . National Heart Foundation of Australia and Cardiac Society of Australia and New Zealand: guidelines for the prevention, detection, and management of heart failure in Australia 2018. Hear Lung Circ. (2018) 27:1123–208. 10.1016/j.hlc.2018.06.1042 - DOI - PubMed
    1. Urbich M, Globe G, Pantiri K, Heisen M, Bennison C, Wirtz HS, et al. . A systematic review of medical costs associated with heart failure in the USA (2014–2020). Pharmacoeconomics. (2020) 38:1219–36. 10.1007/s40273-020-00952-0 - DOI - PMC - PubMed
    1. Baker Heart Diabetes Institute . The Dark Heart of Type 2 Diabetes. (2017). Available online at: https://baker.edu.au/impact/advocacy/dark-heart-diabetes (accessed August 2, 2020).
    1. Jones NR, Hobbs FR, Taylor CJ. Prognosis following a diagnosis of heart failure and the role of primary care: a review of the literature. BJGP Open. (2017) 1:BJGP-2016-0021. 10.3399/bjgpopen17X101013 - DOI - PMC - PubMed